Peptic Ulcer Hemorrhage Clinical Trial
Official title:
China Survey of Peptic Ulcer Bleeding
This will be a multicenter prospective observational study carried out in China. The investigators will collect data in a pre-specified Case Report Form. Main data from each patient will include demographics, endoscopy classification, and both endoscopy and pharmacological treatments received by patients. Data from each patient will be prospectively collected from the day the patient is diagnosed as peptic ulcer bleeding by endoscopy and receives endoscopy treatment if the investigator thinks it is needed and up to 30 days afterwards. The proportion of peptic ulcer bleeding patients who are at high risk is the primary outcome variable. High risk is defined as the patients with endoscopy Forrest classification Ia to IIb. The rate and type of endoscopic treatment, the rate of successful endoscopy treatment, the re-bleeding rate and the endoscopic re-treatment rate in high risk peptic ulcer bleeding patients will be collected. The surgery rate and mortality rate in high risk and overall patient population will be calculated.
n/a
Observational Model: Case-Only, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01125852 -
Supplementary Angiographic Embolization for Peptic Ulcer Bleeding
|
N/A | |
Completed |
NCT00840008 -
The Dissemination of Consensus Recommendations on Upper Gastrointestinal Bleeding
|
Phase 4 | |
Terminated |
NCT00164905 -
Role of Doppler Ultrasound in Severe Peptic Ulcer Hemorrhage
|
N/A | |
Completed |
NCT05563714 -
Anticoagulation With Enhanced Gastrointestinal Safety
|
N/A | |
Completed |
NCT03362281 -
Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients
|
Phase 3 | |
Completed |
NCT00164931 -
A Study Comparing High Dose Omeprazole Infusion Against Scheduled Second Endoscopy for Bleeding Peptic Ulcer
|
Phase 3 | |
Completed |
NCT04211194 -
Registry for Upper Gastrointestinal Bleeding
|
||
Completed |
NCT00037570 -
Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage
|
Phase 2 | |
Completed |
NCT00731601 -
Intravenous Proton Pump Inhibitor for Peptic Ulcer Bleeding
|
Phase 4 | |
Completed |
NCT05248321 -
Precise Delivery of Tranexamic Acid to Enhance Endoscopic Hemostasis for Peptic Ulcer Bleeding
|
N/A | |
Recruiting |
NCT00687336 -
Helicobacter Pylori Empiric Treatment in Ulcer Bleeding
|
Phase 4 | |
Not yet recruiting |
NCT06273384 -
Diagnostic Performance of CIM for Helicobacter Pylori Infection in Patients With Peptic Ulcer Bleeding
|
||
Terminated |
NCT00165009 -
Resolution Endoclips Vs Epinephrine Injection and Heater Probe
|
Phase 3 | |
Completed |
NCT03163680 -
Efficacy of Low Dose of Proton Pump Inhibitor in Treatment Bleeding Ulcers
|
||
Completed |
NCT00279123 -
Effects of 2 Different Doses of Pantoprazole on Gastric pH and Recurrent Bleeding in Patients Who Bled From Peptic Ulcers
|
Phase 4 | |
Completed |
NCT03362268 -
IIaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients
|
Phase 2 | |
Completed |
NCT00573924 -
Trial of Oral Versus Intravenous Proton Pump Inhibitor on Intragastric pH in Patients With Bleeding Ulcers
|
N/A | |
Withdrawn |
NCT02724150 -
Comparison of Low Against High Regimen of Proton Pump Inhibitors for Treatment of Acute Peptic Ulcer Bleeding
|
Phase 4 | |
Active, not recruiting |
NCT04536428 -
ClearEndoclip Versus EZ Clip for Upper Gastrointestinal Ulcer Bleeding
|
N/A | |
Completed |
NCT02197039 -
The Selection Criteria for the Second-look Endoscopy Among Patients With Bleeding Peptic Ulcers
|